Moderna faces significant uncertainty ahead of Q3 earnings, with heavy reliance on COVID vaccine revenues and limited ...

Discover whether Moderna or BioNTech offers better long-term investment potential as both pivot from COVID-19 to innovative ...

It’s that time of year when the leaves are turning golden, there’s a chill in the air and the threat of respiratory viruses ...

Then, demand for its COVID-19 vaccine started to diminish. As hospitals resumed normal operations and anti-vaccine sentiment ...

A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new approach to COVID vaccines: using mRNA to let the body assemble its own ...

Secretary of Health and Human ServicesRobert F. Kennedy, Jr.is under constant siege. The political establishment that has ...

Winter edges in and, like clockwork, Covid-19, influenza and respiratory syncytial virus step back into the ...

A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua ...

TIME Magazine has released its 2025 Innovation Hall of Fame list to celebrate most iconic inventions of this century so far.

From Elon Musk and Satya Nadella to the co-founder of Moderna, it’s not just tycoons in Silicon Valley who have benefited ...

In most European countries, Canada and Australia, COVID vaccine guidance is already limited to older adults and those at high ...

Shah Capital has urged Novavax's board to pursue a sale of the biotech, citing a third consecutive year of poor roll-out of ...